BookFactory Ndas Log Book / Journal / Logbook - 120 Page, 8.5"x11", Black Hardbound (XLog-120-7CS-A-L-Black(Ndas Log Book))
BookFactory Ndas Log Book / Journal / Logbook - 120 Page, 8.5"x11", Black Hardbound (XLog-120-7CS-A-L-Black(Ndas Log Book))
These Professional Grade Ndas Log Books let you record your Work/Activities and are of the Highest Quality. Our Log Books are used by some of the world's most innovative companies and most prestigious research institutions. These log books are essential for rock-solid record keeping.
- ASIN: B00EGH2YKC
- Brand: BookFactory
- Manufacturer: BookFactory
Alone with a Thief (Alone With... Romances Book 2)
Alone with a Thief (Alone With... Romances Book 2)
Grace McMillan is alone, living in an isolated farmhouse at the base of the Cascade Mountains. Lost in grief, she tries to recover from the death of her father.Sean Watson is running after suddenly finding himself an accessory to robbery and murder. Driving north in blind panic, on impulse, he heads towards the mountains. In a forested area, he abandons his car and travels on foot, until he comes across a seemingly abandoned farmhouse, a place to hide.In the night, Grace is awakened by a sound.She finds herself facing a desperate man surprised at the sight of her, and he instantly takes control. Days and nights pass with two strangers trapped together. As she comes to learn his situation is more complicated than it seems, he finds that hers is more tragic than his. Can they risk trusting each other?Grace’s instincts are torn between fear and need as she finds herself alone with a thief.
- ASIN: B01LXG22UF
- Manufacturer: N.D. Author Services [NDAS]
The Future of Drug Discovery: Who Decides Which Diseases to Treat?
The Future of Drug Discovery: Who Decides Which Diseases to Treat?
The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer’s disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease.Provides an in-depth, broad perspective on the crisis in drug industryExposes the disconnect between what society needs and what the drug companies are working onAnalyses and projects over 10 years into the futureExplains what it means for scientists and societyDetermines what is needed to be done to make sure that the industry responds to society's needs, remains commercially attractive and answers the question as to who decides which diseases to treat
- ASIN: 0124071805
- ISBN: 0124071805
- Manufacturer: Academic Press
How SMEs protect critical knowledge in joint innovation activities with external partners
How SMEs protect critical knowledge in joint innovation activities with external partners
Master's Thesis from the year 2011 in the subject Business economics - Business Management, Corporate Governance, grade: Sehr gut, Vienna University of Economics and Business (Entrepreneurship & Innovation), language: English, abstract: For small firms, knowledge leakage, loss and theft are counted among the greatest risks in inter-firm collaborations. SMEs are more vulnerable, because they suffer from a number of structural disadvantages when collaborating with larger companies, and yet, they need to collaborate with external partners to overcome their lack of resources. Therefore, this study investigates how SMEs can most effectively protect critical knowledge in collaborations with external partners, for that they can prevent knowledge loss, leakage and theft, while maximizing the performance of the collaboration. Based on a comprehensive review of existing literature, and a qualitative multiple-case study evaluation, where highly innovative and successful SMEs in Germany contributed their experiences, I have derived valuable insights for practice and theory. Overall, the most commonly used means of protecting critical knowledge were secrecy, patents, the systematic selection of partners, and contracts. Despite the importance given to these mechanisms, not all of them proved to be effective. In fact, trust, secrecy and the systematic selection of partners were considered to be most effective, while initial secrecy and patents were concluded to overprotect knowledge, thus, limiting the possible overall innovative performance. Complementary assets, rotating personnel, oligopolistic market structures, equity relationships, technical means of protection, and employee contracts were found to be entirely ineffective for SMEs. When analyzing the relations of protection mechanisms, a significant correlation between the type of protection and the openness to external innovation emerged: companies, which used initial secrecy and patents to protect knowledge, did not colla... [Read More]
- ASIN: B076Q55VX1
- Manufacturer: GRIN Verlag